O'Dell Group »

Recursion Pharmaceuticals shares owned by O'Dell Group

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by O'Dell Group from 13F filings

Historical chart of O'Dell Group investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by O'Dell Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by O'Dell Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $12k 1.2k 9.86
2023-06-30 $8.8k 1.2k 7.47
2022-09-30 $13k 1.2k 11.06

More positions owned by O'Dell Group

Spdr Ser Tr Portfolio S&p500 (SPLG)
Spdr Ser Tr S&p Divid Etf (SDY)
Ishares Tr Core Div Grwth (DGRO)
First Tr Exchange-traded Nasdq Semcndtr (FTXL)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
First Tr Exchange-traded Dj Internt Idx (FDN)
First Tr Exchange Traded Indls Prod Dur (FXR)
First Tr Nasdaq 100 Tech Ind SHS (QTEC)
Apple (AAPL)
First Tr Exchange Traded Consumr Discre (FXD)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Msci Eafe (IEFA)
Wisdomtree Tr Futre Strat Fd (WTMF)
JPMorgan Chase & Co. (JPM)

View all positions for O'Dell Group

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
Mubadala Investment Co PJSC
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
MIC Capital Management UK
Nvidia Corp
Norges Bank Investment Management
Dimensional Fund Advisors
Credit Suisse
Point72 Asset Management
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Recursion Pharmaceuticals